232 related articles for article (PubMed ID: 8775827)
1. [Lymphoproliferative disease and cancer in the transplant patient].
Herreros J; Flórez S; Echevarría JR; Fernández AL; Pardo Mindán FJ
Rev Esp Cardiol; 1995; 48 Suppl 7():129-34. PubMed ID: 8775827
[TBL] [Abstract][Full Text] [Related]
2. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
3. Malignancy after solid organ transplantation: an overview.
Zafar SY; Howell DN; Gockerman JP
Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
[TBL] [Abstract][Full Text] [Related]
4. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of skin complications from immunodepression in organ transplantation].
Francès C
Bull Acad Natl Med; 2002; 186(6):1067-75; discussion 1076-7. PubMed ID: 12587344
[TBL] [Abstract][Full Text] [Related]
6. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
[TBL] [Abstract][Full Text] [Related]
7. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence after immunosuppressive treatment following kidney transplantation.
Andrés A
Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
[TBL] [Abstract][Full Text] [Related]
9. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
10. [Presentation of cancers in recipients of a solid-organ transplant].
Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
[No Abstract] [Full Text] [Related]
11. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
12. Low incidence of malignancy after transplantation in Chinese heart allograft recipients.
Hsu RB; Chen RJ; Chou NK; Ko WJ; Wang SS; Chu SH
Transpl Int; 2005 Mar; 18(3):283-8. PubMed ID: 15730487
[TBL] [Abstract][Full Text] [Related]
13. [Cancer after kidney transplantation].
Sandrini S; Setti G; Bossini N; Maiorca P
G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
[TBL] [Abstract][Full Text] [Related]
14. The role of mTOR inhibitors in the management of posttransplant malignancy.
Monaco AP
Transplantation; 2009 Jan; 87(2):157-63. PubMed ID: 19155967
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
16. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
17. ["De novo" cancer after organ transplantation].
Launois B; Meunier B; Camus C; Bardaxoglou E; Lakehal M; Caulet-Maugendre S; André P; Ramée MP; Chaperon J; Le Pogamp P; Messner M
Bull Acad Natl Med; 1996 Nov; 180(8):1869-86; discussion 1886-9. PubMed ID: 9138755
[TBL] [Abstract][Full Text] [Related]
18. Dermatopathology of skin cancer in solid organ transplant recipients.
Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer in liver transplant recipients.
Otley CC; Pittelkow MR
Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disorder limited to the skin.
Samolitis NJ; Bharadwaj JS; Weis JR; Harris RM
J Cutan Pathol; 2004 Jul; 31(6):453-7. PubMed ID: 15186434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
